Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized dose-comparison study of ENN0403 in diabetic macular edema
ChiCTR2500098233Phase 2Recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ENN0403 in diabetic macular edema (DME) (2 arms), sponsored by Tianjin Medical University Eye Hospital. Primary endpoint: Change from baseline in central retinal thickness at week 12. Started Mar 2025; status: recruiting.
02
Drugs
ENN0403
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on ChiCTR2500098233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098233.